Home › Parkinson's Disease › Pennsylvania › Pittsburgh
Parkinson's Disease clinical trials in Pittsburgh, PA
6 studies for Parkinson's Disease are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
Recruiting
- University of Pittsburgh, Pittsburgh
Parkinson's Foundation PD GENEration Genetic Registry
RecruitingObservational study
- Allegheny Health Network, Pittsburgh
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
RecruitingObservational study
- Allegheny General Hospital, Pittsburgh
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- Allegheny General Hospital, Pittsburgh
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- University of Pittsburgh, Pittsburgh
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RecruitingPhase 1
- UPMC Presbyterian Hospital, Pittsburgh
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY24 studies
- Boston, MA20 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN16 studies
- San Francisco, CA15 studies
- Philadelphia, PA15 studies
- Miami, FL14 studies
- Farmington Hills, MI14 studies
- New Haven, CT14 studies
- Chicago, IL14 studies
- Charleston, SC13 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)42 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Melanoma31 studies
- Metastatic Cancer31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer24 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.